Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki‐67/CD31

Journal of Cellular and Molecular Medicine

Qian Huang¹  Wenjian Jin²  Ning Zhong²  Qiang Wang³  Wei Zhuang⁴ 

[1] Department of Abdominal Surgery, Jiangxi Provincial Tumor Hospital, Nanchang, China;Department of Geriatric Oncology, Jiangxi Provincial Tumor Hospital, Nanchang, China;Department of Oncology, the People’s Hospital of Ruijin City, Ruijin, China;Jiangxi Health Vocational College, Nanchang, China;

关键词: apatinib;    small cell lung cancer;    targeted therapy;    tumour angiogenesis;    vascular endothelial growth factor;    vascular endothelial growth factor receptor 2;   

DOI  :  10.1111/jcmm.16926

来源: Wiley

【 授权许可】

CC BY